Poxel (XPAR:POXEL) PensionAndRetirementBenefit : €0.25 Mil (As of Dec. 2022)

View and export this data going back to 2015. Start your Free Trial

What is Poxel PensionAndRetirementBenefit?

Poxel's PensionAndRetirementBenefit for the quarter that ended in Dec. 2022 was €0.25 Mil.

Poxel's quarterly PensionAndRetirementBenefit declined from Dec. 2021 (€0.37 Mil) to Jun. 2022 (€0.24 Mil) but then increased from Jun. 2022 (€0.24 Mil) to Dec. 2022 (€0.25 Mil).

Poxel's annual PensionAndRetirementBenefit declined from Dec. 2020 (€0.40 Mil) to Dec. 2021 (€0.37 Mil) and declined from Dec. 2021 (€0.37 Mil) to Dec. 2022 (€0.25 Mil).

Poxel PensionAndRetirementBenefit Historical Data

The historical data trend for Poxel's PensionAndRetirementBenefit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Poxel PensionAndRetirementBenefit Chart

Poxel Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

PensionAndRetirementBenefit

Get a 7-Day Free Trial

0.28

0.38

0.40

0.37

0.25

Poxel Semi-Annual Data
	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22
PensionAndRetirementBenefit	Get a 7-Day Free Trial															0.40	0.54	0.37	0.24	0.25

Poxel PensionAndRetirementBenefit Calculation

PensionAndRetirementBenefit is the carrying amount as of the balance sheet date of the portion of the obligations recognized for the various benefits provided to former or inactive employees, their beneficiaries, and covered dependents after employment but before retirement.

Poxel (XPAR:POXEL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Poxel SA (XPAR:POXEL) » Definitions » PensionAndRetirementBenefit

Comparable Companies

Traded in Other Exchanges

0RA2:UK 7PO:Germany

Address

259/261 Avenue Jean Jaures, Immeuble le Sunway, Lyon, FRA, 69007

Website

https://www.poxel.com

Poxel SA is a biopharmaceutical company. It is focused on the development of novel treatments for metabolic diseases, including type 2 diabetes and liver diseases, such as nonalcoholic steatohepatitis (NASH) and rare disorders (ALD/AMN). It has developed a portfolio of drug candidates, including its candidates: Imeglimin, for the treatment of type 2 diabetes, and PXL770 and PXL065, for the treatment of NASH.

Poxel (XPAR:POXEL) Headlines

No Headlines